Distillate Capital Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.8M Buy
93,721
+708
+0.8% +$152K 1.04% 29
2025
Q4
$19.1M Sell
93,013
-26,101
-22% -$4.91M 0.98% 32
2025
Q3
$18.6M Buy
+119,114
New +$18.4M 0.97% 33
2023
Q1
Sell
-146
Closed -$11.2K 39
2022
Q4
$11.2K Buy
+146
New +$11.1K 1.04% 37

Other funds holding CAH

Distillate Capital Partners's CAH Position: Q1 2026 in Review

Distillate Capital Partners increased its Cardinal Health (CAH) stake by 0.76% in Q1 2026, buying an estimated $152K and bringing the position to 93,721 shares worth $19.8M. The position accounts for 1.04% of the portfolio, ranked #29.

Distillate Capital Partners first reported a position in CAH in Q4 2022 and has held it in 4 quarters since. 1,426 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Distillate Capital Partners held 93,721 shares of Cardinal Health worth $19.8M as of Q1 2026.
  • Distillate Capital Partners bought 708 Cardinal Health shares in Q1 2026, an estimated $152K.
  • Cardinal Health made up 1.04% of Distillate Capital Partners's portfolio in Q1 2026, its #29 holding.
  • Distillate Capital Partners first reported a position in Cardinal Health in Q4 2022 and has held it in 4 quarters since.
  • 1,426 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Distillate Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.